Researchers Identify 4 Antiviral Drug Candidates for COVID-19
A team of researchers screened over 250,000 drugs and natural compounds to find those that stop viral replication the most.
Currently, there are only three antivirals authorized by the US Food and Drug Administration (FDA) for treating COVID-19. If the SARS-CoV-2 virus develops resistance to any of them, treatment options will be severely limited.
To find more treatment options, researchers conducted an extensive search, which led to the identification of four potential candidates for COVID treatment.
Already, the effectiveness of one of the drugs is in question, and another’s efficacy hasn’t yet been pinned down.
- Over 250,000 drugs and natural compounds were screened.
- Four potential candidates for COVID treatment were identified.
Author's summary: Researchers identify new antiviral drug candidates.
More News
- Seth Moulton says he will return, reject AIPAC donations in Senate campaign
- Kansas Department of Labor Receives NASCIO 2025 State Information Technology Recognition Award
- Franklin’s Firing By Penn State Puts Added Pressure on Florida's Decision - WRUF 98.1 FM | 850 AM | 103.7 HD2 ESPN
- Downings artist's work selected for prestigious Art Riddler exhibition - Donegal Daily
- Trump continues retribution as prosecutors move towards John Bolton indictment
- Lithium batteries complicate rollover cleanup - Marysville Journal Tribune
- WRAP releases communication resources for Simpler Recycling rollout
- A roundup of unpublished Photo of the Week submissions
- Baby Emmanuel's father pleads guilty to second-degree murder of his missing 7-month-old son
- 6 Drive-Thru Coffee Lessons Every Operator Should Know